tirzepatide use in pregnancy safety Can the new diabetes and weight loss drugs affect reproductive health? — Those Nerdy Girls tirzepatide pregnancy safety data Long-Term

The risk associated with compounded medicines containing GLP-1 agonists are posed by the absence of the evaluation of these medicines by SAHPRA and the unknown nature and safety of ingredients used in compounding. Compounded products that claim to contain semaglutide have not been verified or evaluated by SAHPRA to determine if the active pharmaceutical ingredient is identical to the registered one, as required by the Medicines Act

Its a frustrating experience that can leave you feeling discouraged

Due to not finding any study similar to ours, we used the data needed for sample size calculation from Kwok et al

Search our database for full COA analytics here